Lord, Abbett & Co
SGYP

Lord, Abbett & Co’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Lord, Abbett & Co’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-335,000
Closed -$1.56M – 960
2017
Q1 		$1.56M Hold
335,000
– – ﹤0.01% 847
2016
Q4 		$2.04M Buy
+335,000
New +$1.75M 0.01% 831
2016
Q1 		– Sell
-714,132
Closed -$4.05M – 988
2015
Q4 		$4.05M Sell
714,132
-169,114
-19% -$1.03M 0.01% 775
2015
Q3 		$4.68M Sell
883,246
-129,642
-13% -$1M 0.01% 756
2015
Q2 		$8.41M Buy
+1,012,888
New +$4.91M 0.02% 672

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lord, Abbett & Co's SGYP Position: Q2 2017 in Review

Lord, Abbett & Co sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2017, closing a stake of 335,000 shares — an estimated $1.56M sold.

Lord, Abbett & Co first reported a position in SGYP in Q2 2015 and held it in 5 quarters. The position peaked at $8.41M in Q2 2015. 146 funds tracked by Wall St. Rank hold SGYP as of Q2 2017.

  • Lord, Abbett & Co reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2017 after selling out during the quarter.
  • Lord, Abbett & Co sold 335,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2017, an estimated $1.56M.
  • Lord, Abbett & Co first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 5 quarters.
  • Lord, Abbett & Co's Synergy Pharmaceuticals, Inc Common Stock position peaked at $8.41M in Q2 2015.
  • 146 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2017.

Based on Lord, Abbett & Co's 13F filing for Q2 2017, filed 14 Aug 2017.